Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

metastatic breast cancer

  • Open Access
    An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients
    CARMEN PACILIO, GERARDO ROSATI, ANNA CRISPO, SABRINA BIMONTE, FRANCESCA DI RELLA, FRANCESCO NUZZO and MICHELINO DE LAURENTIIS
    In Vivo July 2023, 37 (4) 1445-1449; DOI: https://doi.org/10.21873/invivo.13228
  • You have access
    Thrombotic Microangiopathy: A Rare Breast Cancer-associated Complication Treated Successfully With Doxorubicin and Cyclophosphamide
    SAMUEL JALALI, DAKOTA JENNEMAN, ANKITA TANDON and HUNG KHONG
    In Vivo May 2021, 35 (3) 1885-1888; DOI: https://doi.org/10.21873/invivo.12452
  • You have access
    Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies
    MITSUHIRO FURUTA, JUNICHIRO WATANABE, TAKESHI ARAMAKI, AKIFUMI NOTSU and HIROFUMI YASUI
    In Vivo January 2020, 34 (1) 275-282; DOI: https://doi.org/10.21873/invivo.11771
  • You have access
    Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2− Advanced/Metastatic Breast Cancer
    HIROHITO SEKI, TAKASHI SAKURAI, YUKA MAEDA, NAOHIKO OKI, MINA AOYAMA, RYOU YAMAGUCHI, TOSHIKI TOKUDA, TAKUJI KABURAGI, TAKEHIRO OKUMURA, TSUYOSHI KARAHASHI, KENICHIRO NAKAJIMA, KAORI HIGETA and KEN SHIMIZU
    In Vivo November 2019, 33 (6) 2037-2044; DOI: https://doi.org/10.21873/invivo.11701
  • You have access
    Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis
    MICHELANGELO RUSSILLO, GIANLUIGI FERRETTI, ANTONELLO VIDIRI, SIMONA GASPARRO, FRANCESCO COGNETTI, DOMENICA PELLEGRINI and ALESSANDRA FABI
    In Vivo July 2018, 32 (4) 839-842; DOI: https://doi.org/10.21873/invivo.11317
In Vivo

© 2026 In Vivo

Powered by HighWire